image credit: Adobe Stock

Venture capital healthtech funding drops 41.2% as firms brace for economic decline

September 14, 2022


Venture capital (VC) financing within healthtech has fallen 41.2% compared to the same time last year. The Asia-Pacific region had the largest year-on-year decrease (-64.8%), followed by Europe (-45.8%), and North America (-38.7%). In contrast, funding for the Middle East and Africa, and South and Central America markets grew by 158.7% and 16.4%, respectively. North America remains the largest funding market, accounting for approximately 70% of all VC deals in healthtech.

Read More on Medical Device Network